GlassScriptPhysician profile
Conor T Flavin
NPI 1235793811
$10,758.84
in general payments reported to CMS, 2019-2025
3 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $85.00 · 2024: $310 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,091 · Travel and Lodging: $960 · Food and Beverage: $623 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,091.00 |
| Travel and Lodging | $960.26 |
| Food and Beverage | $622.58 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,308.48 | 2025 | Infinity, Proclaim |
| Merz Pharmaceuticals, LLC | $323.36 | 2023-2024 | Xeomin |
| Amneal Pharmaceuticals LLC | $127.00 | 2024-2025 | Crexont |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conor Flavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.